INNOVACAP vs RPGLIFE: Stock Comparison

Innova Captab Limited vs RPG Life Sciences Limited

Live data: 22 July 2026, 3:07 PM IST • Source: NSE and company filings

Innova Captab Limited is the larger company by market capitalisation. Innova Captab Limited shows a lower P/E and faster revenue growth, while RPG Life Sciences Limited shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Innova Captab Limited and RPG Life Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INNOVACAP is more favourable on 5 of 13 scored metrics and RPGLIFE on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
INNOVACAP is the larger company
₹5,605 Cr vs ₹4,976 Cr
P/E Ratio
INNOVACAP has a lower P/E
39.74x vs 43.37x
P/B Ratio
INNOVACAP has a lower P/B
5.14x vs 8.25x
EPS
RPGLIFE has higher earnings per share
₹69.65 vs ₹24.62
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0.41%
Revenue Growth (TTM YoY)
INNOVACAP has faster revenue growth
42.3% vs 23.6%
EPS Growth (TTM YoY)
INNOVACAP has faster EPS growth
28.6% vs -74.5%
Qtr Sales Growth
INNOVACAP has stronger quarterly sales growth
42.3% vs 23.6%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINNOVACAPRPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricINNOVACAPRPGLIFE
Live Price₹976.25₹3,014.9
Day Change-0.39%0.57%
Volume36,47130,874
52-Week High₹1,034.85₹3,082
52-Week Low₹622₹1,733
Distance from 52W High-5.66%-2.18%

Valuation

MetricINNOVACAPRPGLIFE
Market Cap₹5,605 Cr₹4,976 Cr
P/E Ratio39.74x43.37x
P/B Ratio5.14x8.25x
EPS₹24.62₹69.65
Book Value₹190.62₹366.04
Dividend Yield0.41%0.75%

Growth

MetricINNOVACAPRPGLIFE
Revenue Growth (TTM YoY)42.3%23.6%
EPS Growth (TTM YoY)28.6%-74.5%
Qtr Sales Growth42.3%23.6%
Qtr Profit Growth28.8%33.7%

Profitability & Leverage

MetricINNOVACAPRPGLIFE
ROE13.7%19.3%
ROCE15%25.7%
Net Margin8.65%29.25%
Operating Margin14.9%20.9%
Debt to Equity0.32x0.03x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINNOVACAPRPGLIFE
Promoter Holding50.9%72.95%
FII Holding0.34% 0.11 pp0.87% 0.13 pp
DII Holding19.92% 0.22 pp7.45% 0.41 pp
Public Holding28.84% 0.11 pp18.73% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Innova Captab Limited and RPG Life Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.